Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nancy Wysenski

Affiliations

  • Director at Alkermes Plc. (ALKS), 2020-05-22
  • Director at Provention Bio Inc. (PRVB), 2020-05-21
  • Director at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Director at Tetraphase Pharmaceuticals Inc (TTPH), 2019-06-11
  • Director at Inovio Pharmaceuticals Inc. (INO), 2016-05-16
  • Evp, Chief Commercial Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), 2012-06-01
  • Officer at Endo Pharmaceuticals Holdings Inc (ENDP), 2009-03-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALKS $19.65 6,940 Director 11,242 2020-02-24 Filing
ALKS $33.06 445 Director 4,302 2019-03-14 Filing
ALKS $33.09 3,857 Director 3,857 2019-02-21 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VRTX $65.00 372 Officer 32,232 2012-05-14 Filing
VRTX $64.27 179,628 Officer 32,604 2012-05-14 Filing
VRTX $65.00 372 Officer 32,232 2012-05-14 Filing
VRTX $64.27 179,628 Officer 32,604 2012-05-14 Filing
VRTX $63.52 18,750 Officer 31,394 2012-05-08 Filing